CONCLUSIONS: In this nationwide ecological study based on annually aggregated data, methylphenidate dispensing more than tripled in France between 2014 and 2024, with steeper post-2022 trends, while regional disparities remained observable and showed no clear convergence. Because the 2021 prescription reform coincided with the COVID-19 period and other changes in ADHD care, these findings should be interpreted as descriptive population-level trends rather than evidence of a specific reform…
